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Edited by Francesc PosasAbstract Caldesmon (CaD) is thought to regulate smooth mus-
cle contraction, because it binds actin and inhibits actomyosin
interactions. A synthetic actin-binding peptide (GS17C) corre-
sponding to Gly666–Ser682 of chicken gizzard CaD has been
shown to induce force development in permeabilized smooth mus-
cle cells. The mechanism of GS17C’s action remains unclear,
although a structural eﬀect was postulated. By photo-crosslink-
ing and ﬂuorescence quenching experiments with a gizzard
CaD fragment (H32K; Met563-Pro771) and its mutants, we
showed that GS17C indeed dissociated the C-terminal region
of H32K from actin, in a manner similar to extracellular sig-
nal-regulated kinase-mediated phosphorylation, thereby revers-
ing the CaD-imposed inhibition and enabling the actomyosin
interaction.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Initially isolated as a calmodulin-binding protein from
smooth muscles [1], caldesmon (CaD) also binds myosin with
its N-terminal domain [2–4], and F-actin with its C-terminal
domain [5–8]. Binding of CaD to actin inhibits the weak inter-
action between actin and myosin [2], and thereby attenuates
the actomyosin ATPase activity [9]. It is generally accepted
that through actin binding CaD plays an inhibitory role
in vivo [10], and provides ﬁne-tuning of the contractile force
in the diverse smooth muscle activities [11,12].
Both actin binding and the inhibitory eﬀect on the actomy-
osin ATPase activity of CaD are reversed either by Ca2+/cal-
modulin [13,14] or partially by phosphorylation [15].
Mitogen-activated protein kinases (MAPKs) phosphorylate
CaD at Ser759 and Ser789 (in the mammalian sequence) as
well as other potential sites when smooth muscle is stimulated
[16,17]. The physiological signiﬁcance of such phosphorylation
has been controversial, primarily because of conﬂicting reportsAbbreviations:BPM, benzophenonemaleimide; CaD, caldesmon;DTT,
dithiothreitol; ERK, extracellular signal-regulated kinase; IAEDANS
(or AEDANS when attached to a protein), 5-(iodoacetamidoethyl)
aminonaphthalene-1-sulfonic acid; MALDI-TOF, matrix-assisted laser
desorption ionization time-of-ﬂight; MAPK, mitogen-activated protein
kinase
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is aﬀected by MAPK [18–20]. However, more recent biochem-
ical studies seem to support a regulatory role for MAPK-med-
iated phosphorylation [21,22].
GS17C, a synthesized peptide encompassing the sequence
corresponding to the segment of Gly666–Ser682 of avian
smooth muscle CaD, is able to bind both calmodulin and actin
[23], and induces dose-dependent and tissue speciﬁc force
development [24]. The magnitude of contractility ‘‘unleashed’’
by the peptide was maximal at low Ca2+, but decreased at high
Ca2+. On the basis of the biochemical properties of this pep-
tide, it was postulated that GS17C competes with the endoge-
nous CaD, presumably by ‘‘nudging’’ away portions of the
CaD molecule from F-actin, and thereby reverses the inhibi-
tion. Such a mechanism is reminiscent of the action resulting
from phosphorylation.
We have previously shown that the C-terminal region of
CaD interacts with actin via multiple actin contact points that
may be grouped into two clusters. Phosphorylation by extra-
cellular signal-regulated kinases (ERKs) results in dissociation
of one of these two actin-binding clusters, leaving the other
one bound to actin. By such a conformational change ERK-
mediated phosphorylation could reverse the CaD-induced
inhibition of actomyosin interaction [22]. This model was fur-
ther supported by 3D reconstruction of actin ﬁlaments deco-
rated with a CaD fragment, ﬂuorescence quenching and
photo-crosslinking experiments [25]. In the present work, we
have examined the structural eﬀects of the synthesized peptide
GS17C on CaD using similar approaches. We found that the
peptide induces a conformational change in the C-terminal re-
gion of CaD similar to that induced by ERK phosphorylation.2. Materials and methods
2.1. H32K fragments
Both CaD fragments used in this work have been described previ-
ously [22,25]: H32K, a His-tagged fragment containing the C-terminal
region sequence (Met563-Pro771) of chicken gizzard CaD, and
H32Kqc/ca, a double mutant of H32K with Gln766 replaced by Cys
and Cys595 replaced by Ala (i.e., Q766C/C595A). H32K has a single
Cys residue at position 595, while H32Kqc/ca has a single Cys766 near
the C-terminus, close to the ERK phosphorylation site. Both frag-
ments can be speciﬁcally labeled at the respective Cys residues.2.2. Synthetic peptides
GS17C (GVRNIKSMWEKGNVFSS-C) and the scrambled pep-
tide, XGS17C (SGWSVEFRMVNKNISGK-C) were synthesized on
an automated peptide synthesizer and puriﬁed by FPLC as previously
described [23,24].blished by Elsevier B.V. All rights reserved.
Table 1
Eﬀect of GS17C on actin binding of H32K segments as analyzed by
mass spectrometry
m/z Residues Relative peak heightsa
Supernatant Pellet
GS17C XGS17C GS17C XGS17C
1677 K676-E692
(or K744-E760)b
27 6 32 49
3881 Q639-E675 122 60 37 68
3946 K676-E713 19 7 30 54
aRelative quantity of each species was obtained by using the peak
heights of species that are not aﬀected by the added peptide as internal
standards.
bBoth K676-E692 and K744-E760 have the same mass, therefore are
indistinguishable by mass analysis.
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CaD fragments were digested by V8 protease either before or after
mixing with F-actin in the presence GS17C or XGS17C, followed by
ultracentrifugation as described previously [22]. The resulting superna-
tant and pellet were mixed with a-cyano-4-hydroxycinnamic acid
matrix and subjected to matrix-assisted laser desorption ionization
time-of-ﬂight (MALDI-TOF) mass spectrometric analysis.
2.4. Fluorescence quenching experiments
CaD fragments were ﬁrst reduced with 10 mM dithiothreitol (DTT)
for 1 h at room temperature, followed by extensive dialysis to remove
DTT against 20 mM Tris–HCl (pH 7.5), 50 mM NaCl, 1 mM EDTA.
A ﬁvefold molar excess of 5-(iodoacetamidoethyl) aminonaphthalene-
1-sulfonic acid was then added from a 20 mM stock solution in
dimethylformamide; the samples were rotated for 4 h at room temper-
ature. The reaction was terminated with 5 mM DTT, and the samples
were dialyzed against 20 mM Tris–HCl (pH 7.5), 50 mM NaCl. The
amount of incorporated AEDANS label was determined by absorp-
tion spectroscopy using an extinction coeﬃcient of 13600 at 350 nm
for AEDANS. The labeled CaD fragment was mixed with F-actin,
in the presence of either GS17C or XGS17C, in F-buﬀer (2 mM
HEPES, pH 7.5, 0.2 mM CaCl2, 50 mM NaCl, 2 mM MgCl2,
0.4 mM ATP). Acrylamide was then added and the ﬂuorescence
monitored using a Cary Eclipse Fluorescence Spectrophotometer with
excitation wavelength ﬁxed at 335 nm and emission wavelength at
494 nm.
2.5. Photo-crosslinking experiments
All operations were performed in the dark. Freshly reduced H32K
fragments (see above) were reacted with a ﬁvefold molar excess of ben-
zophenone maleimide (BPM), and the sample was rotated for 5 h at
room temperature. The reaction was quenched with 5 mM DTT, and
the sample dialyzed against 20 mM Tris–HCl, pH 7.5, 50 mM NaCl.
H32K-BPM and F-actin were then mixed in F-buﬀer (50 mM NaCl,
2 mM MgCl2, 2 mM HEPES, pH 7.5, 0.2 mM CaCl2, 0.4 mM ATP)
with GS17C or XGS17C. UV irradiation was carried out in a Rayonet
RPR-100 photochemical reactor equipped with 16 3500 lamps
(Southern New England Ultraviolet) at 4 C for 15 min. Thin ﬁlaments
were centrifuged with a Ti-100.2 rotor at 80 K rpm for 30 min at 20 C.
The crosslinked products in pellets and supernatants were analyzed
with 4–20% gradient SDS–polyacrylamide gels (Bio-Rad).
2.6. Actomyosin ATPase activity assay
Rabbit skeletal actin (3 lM) and gizzard tropomyosin (0.5 lM), in
the presence of H32K (5 lM) with GS17C or XGS17C (15 lM), were
incubated with rabbit skeletal muscle myosin S1 (0.5 lM). The reac-
tion was initiated by addition of 2 mM ATP. Release of inorganic
phosphate (10 min at 37 C) was determined in quadruplicate by using
an improved molybdate method [26] on microtitre plates. Reaction
mixtures without actin or myosin were used as controls.3. Results and discussion
3.1. GS17C competes with its corresponding segment in H32K
for actin-binding
The GS17C peptide is known to interact with F-actin by
itself [23]; presumably it contains part of the actin-binding se-
quence. However, GS17C failed to displace CaD from F-actin,
because CaD contains multiple actin-binding sites and not all
are aﬀected by GS17C [22]. To test whether GS17C competes
with any parts of the CaD molecule for actin binding, we have
cleaved H32K with V8 protease, and then co-sedimented the
digest mixture with F-actin in the absence or presence of added
GS17C. Both the supernatant and pellet fractions were
checked with mass spectrometry. We found that the peak
heights of species with masses (m/z) of 1677, 3881, and 3946,
which represent the segments of K676-E692 (or K744-E760),
Q639-E675, and K676-E713, respectively, increased in the
supernatant and decreased in the pellet (Table 1) after additionof GS17C, indicating that GS17C indeed competes with its
corresponding segment (Gly666–Ser682) in H32K for binding
to actin. The absence of changes for other peaks in the pellet
fraction indicated that, after cleavage, the actin-binding capac-
ity of peptide segments in other regions are not aﬀected by
GS17C.3.2. GS17C increases the solvent accessibility at both positions
766 and 595
To determine the eﬀect of GS17C on the conﬁguration of the
actin-bound CaD fragment, we ﬁrst examined the solvent
accessibility of an attached ﬂuorescence probe (AEDANS)
by ﬂuorescent quenching in the presence and absence of
GS17C. A mixture of F-actin and AEDANS-labeled H32K
(with the probe attached to Cys595) or H32Kqc/ca (with the
probe attached to Cys766) was titrated with acrylamide, which
served as a quencher. In both cases the ﬂuorescence intensity
of AEDANS was decreased. The reciprocals of the relative
ﬂuorescence intensity (Fo/F) of H32K or H32Kqc/ca, in the
presence of GS17C or a control peptide XGS17C that contains
a randomized sequence of the same residues, were plotted as a
function of acrylamide concentration (the Stern–Volmer Plot,
Fig. 1). From the slopes of such plots, which reﬂect the solvent
accessibility of the probe, it is clear that addition of GS17C
rendered the probe more exposed to the solvent at both posi-
tions. It should be noted that, as a control, the solvent acces-
sibility of the same probe was not aﬀected by either peptide
when F-actin was not present. Thus the increased quenching
could be best interpreted as GS17C-induced partial dissocia-
tion of the CaD fragment from F-actin.
This ﬁnding was diﬀerent from the results obtained with
ERK phosphorylation (at Ser717), which only aﬀected the sol-
vent accessibility of the nearby Cys766, but not Cys595 [22].
Apparently, GS17C perturbed not only the portion of the
CaD molecule that is near its own sequence (Gly666–
Ser682), but also regions further downstream that are remote
from the GS17C sequence. Since such a long-range eﬀect was
only observed when the H32K fragment was intact, but not
after proteolytic digestion (see above), it must involve a con-
formational change in H32K induced by GS17C.3.3. GS17C increases the susceptibility of the C-terminal regions
of CaD when bound to F-actin
We have used enzymatic digestion to test the structural con-
sequences of GS17C on the CaD fragment. H32K was ﬁrst
Fig. 1. Stern–Volmer plot of AEDANS-labeled H32K and H32Kqc/ca
quenched by acrylamide. The reciprocal of the relative ﬂuorescence
intensity (Fo/F) of H32K (open symbols and thin traces) or H32Kqc/ca
(closed symbols and thick traces), in the presence of GS17C (circles
and solid lines) or scrambled peptide XGS17C (squares and broken
lines), were plotted as a function of acrylamide concentration. All data
sets have the same initial value of 1.0. The straight lines are the best ﬁts
obtained by assuming linearity for the changes. The slopes (the Stern–
Volmers constant, Ksv), which reﬂect the solvent accessibility of the
probe at respective positions, are 7.97 (with GS17C) and 5.50 (with
XGS17C) for Cys595 in H32K, and 9.03 (with GS17C) and 5.85 (with
XGS17C) for Cys766 in H32Kqc/ca.
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lowed by co-sedimentation and then the pellet fraction was di-
gested with V8 protease in F-buﬀer; the resulting materials
were again checked by MALDI-TOF mass spectrometry. We
found that the species with mass (m/z) of 1319, 1677 and
2248, corresponding to the segments of T761-P771, K676-Fig. 2. Eﬀect of GS17C on photo-crosslinking between CaD fragments and ac
irradiated with UV light. Panel A, lane M, molecular weight markers; lane 1, F
presence ofGS17C; lane 4, H32K-BPMwithF-actin in the presence ofXGS17C
H32Kqc/ca alone; lane 3,H32Kqc/ca-BPMwithF-actin in thepresence ofGS17
arrows indicate the crosslinked product of CaD fragment and actin. The band i
(Lane 3) and 58473 (Lane 4) for H32K (Panel A), and 5472 (Lane 3) and 32699
diminished the yield of photo-crosslinking between CaD fragments and actin a
migrate with the dye front. Other minor species visible on the gels include dime
the dimer and actin (90 kDa).E692 (or K744-E760) and K739-E760, respectively, which were
either absent or in negligible amount when XGS17C was used,
emerged only when GS17C was present. This indicated that
GS17C, but not XGS17C, induces a conformational change
at the C-terminal end of H32K, somehow making it more sus-
ceptible to proteolytic digestion.
3.4. Eﬀect of GS17C on photo-crosslinking of H32K-BPM and
H32Kqc/ca-BPM with F-actin
To further examine the conformational eﬀect of GS17C on
the C-terminal region of CaD, we have performed photo-
crosslinking experiments between CaD fragment and F-actin.
H32K or H32Kqc/ca labeled with BPM was mixed with F-
actin and irradiated with UV light in the presence of GS17C
or XGS17C. In both cases GS17C attenuated the yield of
crosslinked product (75 kDa) between CaD fragment and
actin compared to XGS17C (Fig. 2). Digitization of the scanned
gel pictures indicated 7.3- and 6-fold decreases in the cross-
linked band intensity for H32K and H32Kqc/ca, respectively.
The lowered crosslinking eﬃciency is consistent with a greater
solvent accessibility (Fig. 1), both reﬂecting a greater distance
between actin and the attached probes at either position 595 or
766, which amounts to a partial dissociation at both regions.
Since the peptide segment near the C-terminus is responsible
for the inhibitory action of CaD [8], such a partial dissociation
induced by GS17C would explain the observed reversal of inhi-
bition [24]. In this sense, the end eﬀect of GS17C is similar to
that of ERK phosphorylation.
3.5. Eﬀect of GS17C on actomyosin ATPase activity
Finally, we examined the eﬀect of GS17C on the inhibitory
action of CaD on the acto-S1 ATPase activity. With H32K
present in slightly excess amount (1.7:1) over actin, which re-
sulted in 46% inhibition of the activity, addition of GS17C
(3-fold of H32K) partially restored the activity (to 75%; Table
2). The same amount of XGS17C did not change the activity.tin. H32K or H32Kqc/ca labeled with BPMwas mixed with F-actin and
-actin alone; lane 2, H32K alone; lane 3, H32K-BPMwith F-actin in the
.Panel B, laneM, molecularweightmarkers; lane 1, F-actin alone; lane 2,
C; lane 4,H32Kqc/ca-BPMwithF-actin in the presenceofXGS17C.The
ntensities of this species were determined by using IPLabGel LC as 7973
(Lane 4) for H32Kqc/ca (Panel B). Thus compared to XGS17C, GS17C
t both positions 595 and 766. Note the peptides (GS17C and XGS17C)
rs of H32K or H32Kqc/ca (60 kDa) and crosslinked products between
Table 2
Eﬀect of GS17C on the acto-S1 ATPase activity
CaD fragment/peptide added Relative ATPase activity (%)
None 100
H32K 54.0 ± 6.8
H32K + GS17C 75.4 ± 3.0
H32K + XGS17C 50.3 ± 4.7
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consistent with the conformational change observed in the
ﬂuorescence quenching and photo-crosslinking experiments,
thus may account for the activation of smooth muscle contrac-
tion as previously reported [24].
4. Conclusions
We have previously shown that both acrylamide quenching
and photo-crosslinking experiments supported the hypothesis
that ERK-mediated phosphorylation of CaD renders the la-
bel attached at position 766 more accessible, while that at po-
sition 595 not much aﬀected, indicating that the C-terminal
region of CaD undergoes a conformational change upon
ERK phosphorylation [22]. 3D reconstruction further demon-
strated that the C-terminal CaD fragment binds actin on the
inner portion of subdomain 1 and forms a bridge to the
neighboring actin monomer of the adjacent long pitch helical
strand by connecting to its subdomain 3 [25]. ERK-phos-
phorylation disrupts such an inter-strand connectivity of
H32K, moves the C-terminal end segment of CaD away from
F-actin, and confers the observed reversal of its inhibitory ef-
fect. GS17C competes with the segment corresponding to its
own sequence for actin binding and displaces part of the CaD
molecule away from F-actin. That GS17C is also able to
make the C-terminal end of H32K further downstream more
susceptible to proteolysis, indicates that this is a long-range
eﬀect. The consequence of such a structural change is to ren-
der the myosin-binding site on subdomain 1 of actin more ex-
posed, analogous to that induced by ERK phosphorylation.
Therefore the earlier reported contraction in tonic smooth
muscles induced by the GS17C peptide can be understood
by such reversal of CaDs inhibitiory eﬀect similar to ERK-
mediated phosphorylation of CaD.
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